Social Impact Capital β Full Portfolio
12 tracked investments Β· listed companies and verified rows first
Curemark is a clinical-stage biopharmaceutical company developing therapies for neuro-developmental and neurodegenerative disorders.
BiotechHealthtechRye Brook, US
Joan Fallon(Executive Officer, Director)inMatthew Heil(Executive Officer)in
BoardLeigh Morgan(Director)Kimbell Duncan(Director)
Board seatJustin StebbingΒ· per SEC Form D Β· $150M raise Β· filed Mar 2017
BiotechDallas, US
Ganesh Raj(Director)inRussell Hayward(Executive Officer, Director)
BoardAnnalisa Jenkins(Director)
Board seatJustin StebbingΒ· per SEC Form D Β· $3M raise Β· filed May 2026
Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Marco Lobba(Founder)inMatthew Francis(Founder)in
Co-investorsCivilization Ventures Management, LlcIaso VenturesY CombinatorAxial VCLongeVCMBX Capital
Charm Industrial converts agricultural residues into bio-oil and injects it underground to remove carbon from the atmosphere at scale.
AgTechCleantechClimate Tech
Shaun Meehan(Chief Scientist and co-founder)in
Co-investorsAzolla VenturesBreyer CapitalCongruent VenturesKinnevikLIONHEART VENTURESPrime Impact Fund+8 more
Lami provides a digital platform that enables insurance agents in sub-Saharan Africa to access quotes, connect with customers, and manage sales.
FintechImpact & Social GoodInsurTechSaaS
Jihan(Founder & CEO)Roy(Co-Founder & CFO)
Co-investorsA15AccionChui VenturesConsonance Investment ManagersP1 VenturesAccion Venture Lab+3 more
Limelight Steel reimagines iron and steelmaking through new industrial technology approaches.
Advanced ManufacturingClimate TechDeep Tech
Co-investorsCantos VenturesCollaborative FundVoyager Partners
Menten AI develops generative AI software to design cyclic peptide therapeutics for drug targets beyond the reach of conventional small molecules and biologics.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Tamas Gorbe(Founder)inHans Melo(Founder)in
Co-investorsY CombinatorKhosla VenturesUncork CapitalAlumni VenturesBasecamp Fundbig_bets
MilkRun connects small farmers directly with local customers through a proprietary delivery platform, bypassing traditional distribution intermediaries.
AgTechB2B MarketplacesConsumerE-commerceFoodTechMarketplacesPortland, US
Julia Niiro(Founder)in
Co-investorsBrighter CapitalY CombinatorRise of the Rest SeedSpark Capital
Praan develops technology to capture air pollution and greenhouse gases as part of an effort to reduce atmospheric carbon and improve air quality.
CleantechClimate TechDeep TechHardware
Angad Daryani(Founder)in
Co-investorsBetter CapitalCool Climate CollectiveSnow Leopard Technology VenturesAera VCWEH Ventures
Totus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Neil Dhawan, PhD(Co-Founder)Nassim Usman, PhD(CEO and President)
Co-investorsDCVC (Data Collective)
Tumoni is a mobile app for receiving money transfers from the United States into a digital wallet, aimed at people receiving remittances from family abroad.
FintechNew York, US
Gregor Freund(Executive Officer, Director)inPaolo Delaunay(Executive Officer, Director)in
BoardYulio Stobbe(Director)
Co-investorsNuMundo VenturesCounterview CapitalSlauson & Co.
Voyage Foods develops B2B ingredients that create sustainable, stable alternatives to traditional commodity sources for popular foods and beverages, addressing volatility in global ingredient markets and climate risks.
AgTechClimate TechFoodTechOakland, US
Adam Maxwell(Executive Officer, Director)
BoardStephen George(Director)Alec Lee(Director)James Stewart(Director)inGary Wu(Director)
Co-investorsBloom8Cerity Partners VenturesCollaborative FundHorizons VenturesLevel One FundNimble Partners+2 more
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.